A Biomimetic Follicle‐Based Design for Engineering Reproductive Technologies
Source abstract
Abstract
Abstract In the field of assisted reproductive technologies, oocyte in vitro maturation (IVM) has emerged as a potential alternative to overcome the limitations associated with standard ovarian stimulation treatments. However, current IVM protocols lack standardization and yield oocytes of inferior quality compared to those matured in vivo. To address this issue, novel biomaterials like hydrogels offer distinct advantages in cell culture by providing a 3D cellular environment and facilitating easy adjustment and characterization of mechanical properties, such as hydrogel stiffness. Herein, a novel and reusable bilayer hydrogel system is presented that accurately mimics the mechanical properties of the microenvironment surrounding oocyte maturation. The system comprises an outer layer fabricated from either a 3D‐printed synthetic polymer (2‐vinyl‐4,6‐diamino‐1,3,5‐triazine, (VDT)) or a natural polymer (chitosan), along with an inner layer composed of alginate. By faithfully replicating the mechanical properties of native tissue within a 3D culture environment, this system significantly improves the quality and developmental capacity of oocytes, thus resulting in successful embryo development. Overall, this innovative system holds great potential for future medical research and applications in cell culture, thus representing a significant advancement in assisted reproductive technologies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Reproductive Biology and Fertility · 3D Printing in Biomedical Research · Ovarian function and disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Instituto Regional de Investigación Científica Aplicada (IRICA) and Facultad de Ciencias y Tecnologías Químicas Universidad de Castilla‐La Mancha Ciudad Real 13071 Spain
SaBio IREC (CSIC‐UCLM‐JCCM) ETSIAMB Campus Universitario s/n Albacete 02071 Spain
Funding
Junta de Comunidades de Castilla-La Mancha · Universidad de Castilla-La Mancha · HORIZON EUROPE Framework Programme · Ministerio de Ciencia e Innovación
References (73)
Show source-provided references
1. Fortune Business Insights In Vitro Fertilization Market Size Share & Industry Analysis 2018 https://www.fortunebusinessinsights.com/industry‐reports/assisted‐reproductive‐technology‐art‐market‐101811.
2. Jones H. W. · Facts Views Vis Obgyn · 2010 · 2 · 169
3. 10.1177/174550571666474310.1177/1745505716664743 ↗
4. 10.5653/cerm.2014.41.2.4110.5653/cerm.2014.41.2.41 ↗
5. Sambasiva B. · Vitr. Cell Dev. Biol. Anim. · 2015 · 51 · 19
6. 10.3390/biomedicines912190410.3390/biomedicines9121904 ↗
7. 10.3390/cells1110169910.3390/cells11101699 ↗
8. Kapałczyńska M. · Arch. Med. Sci. · 2016 · 14 · 910
9. 10.3390/biology1011110110.3390/biology10111101 ↗
10. 10.1002/vms3.89110.1002/vms3.891 ↗
11. 10.1016/j.theriogenology.2020.07.01610.1016/j.theriogenology.2020.07.016 ↗
12. 10.1371/journal.pone.023881210.1371/journal.pone.0238812 ↗
13. 10.1111/rda.1360210.1111/rda.13602 ↗
14. 10.1016/j.bbadis.2013.02.00710.1016/j.bbadis.2013.02.007 ↗
15. 10.1016/j.biomaterials.2021.12109910.1016/j.biomaterials.2021.121099 ↗
16. 10.1016/j.semcdb.2017.07.02710.1016/j.semcdb.2017.07.027 ↗
17. 10.3390/ijms2301005410.3390/ijms23010054 ↗
18. 10.1016/j.bpj.2016.03.02310.1016/j.bpj.2016.03.023 ↗
19. 10.1038/s42003-021-02662-510.1038/s42003-021-02662-5 ↗
20. 10.1039/C9NR10588C10.1039/C9NR10588C ↗
21. 10.1016/j.progpolymsci.2011.06.00310.1016/j.progpolymsci.2011.06.003 ↗
22. 10.1016/j.biomaterials.2007.07.00110.1016/j.biomaterials.2007.07.001 ↗
23. 10.1007/s12522-011-0079-410.1007/s12522-011-0079-4 ↗
24. 10.3389/fcell.2021.71029210.3389/fcell.2021.710292 ↗
25. 10.1095/biolreprod.107.06601910.1095/biolreprod.107.066019 ↗
26. 10.1093/humrep/14.7.185910.1093/humrep/14.7.1859 ↗
27. 10.1016/j.ijvsm.2018.02.00310.1016/j.ijvsm.2018.02.003 ↗
28. 10.3389/fendo.2018.0032710.3389/fendo.2018.00327 ↗
29. 10.1016/j.reth.2021.09.00810.1016/j.reth.2021.09.008 ↗
30. 10.1016/j.theriogenology.2021.01.00810.1016/j.theriogenology.2021.01.008 ↗
31. 10.1093/oxfordjournals.humrep.a01942110.1093/oxfordjournals.humrep.a019421 ↗
32. 10.1016/j.fertnstert.2003.12.03910.1016/j.fertnstert.2003.12.039 ↗
33. 10.1017/S096719941900024810.1017/S0967199419000248 ↗
34. 10.1016/j.fertnstert.2020.10.04510.1016/j.fertnstert.2020.10.045 ↗
35. 10.1089/ars.2019.798410.1089/ars.2019.7984 ↗
36. 10.1007/s10815-017-0998-z10.1007/s10815-017-0998-z ↗
37. 10.3389/fphar.2020.0069710.3389/fphar.2020.00697 ↗
38. Dong R. · Front. Bioeng. Biotechnol. · 2022 · 10 · 1
39. 10.2147/DDDT.S21721110.2147/DDDT.S217211 ↗
40. Homburg R. · 2014 · Ch. 0510.1007/978-3-319-05612-8 ↗
41. 10.1371/journal.pone.010813910.1371/journal.pone.0108139 ↗
42. 10.1007/s10815-018-1268-410.1007/s10815-018-1268-4 ↗
43. 10.1055/s-0028-110800810.1055/s-0028-1108008 ↗
44. 10.1242/dev.02002410.1242/dev.020024 ↗
45. 10.1095/biolreprod.103.02120410.1095/biolreprod.103.021204 ↗
46. 10.1186/s12958-015-0091-310.1186/s12958-015-0091-3 ↗
47. 10.1186/s13048-020-00696-710.1186/s13048-020-00696-7 ↗
48. 10.1530/rep.0.126002710.1530/rep.0.1260027 ↗
49. 10.1095/biolreprod.104.02970210.1095/biolreprod.104.029702 ↗
50. 10.1093/biolre/ioz04910.1093/biolre/ioz049 ↗
51. 10.1126/sciadv.aav996010.1126/sciadv.aav9960 ↗
52. 10.1210/endrev/bnac01310.1210/endrev/bnac013 ↗
53. 10.1038/s41586-021-04267-810.1038/s41586-021-04267-8 ↗
54. 10.1016/j.tcb.2015.05.00210.1016/j.tcb.2015.05.002 ↗
55. 10.2147/OTT.S26664910.2147/OTT.S266649 ↗
56. 10.1093/humupd/dmx04010.1093/humupd/dmx040 ↗
57. 10.1007/s10439-019-02428-510.1007/s10439-019-02428-5 ↗
58. 10.3389/fbioe.2022.81739110.3389/fbioe.2022.817391 ↗
59. 10.21037/atm-21-618910.21037/atm-21-6189 ↗
60. 10.1016/j.actbio.2017.10.00710.1016/j.actbio.2017.10.007 ↗
61. 10.1016/j.theriogenology.2008.10.02310.1016/j.theriogenology.2008.10.023 ↗
62. 10.1186/s12978-020-0870-y10.1186/s12978-020-0870-y ↗
63. 10.3390/cells906155010.3390/cells9061550 ↗
64. 10.3390/ani1221305710.3390/ani12213057 ↗
65. N.Sawa T.Masuda (Shikoku Chemicals Corp) EP0211121A1 1986.
66. M.Bispinghoff A.Schmocker A.Johnson (Lumendo Ag) US20230172813A1 2022.
67. 10.1016/j.theriogenology.2022.04.00110.1016/j.theriogenology.2022.04.001 ↗
68. 10.3390/ani1109251210.3390/ani11092512 ↗
69. 10.1038/nprot.2008.7310.1038/nprot.2008.73 ↗
70. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
71. 10.3390/ani1012241410.3390/ani10122414 ↗
72. 10.1016/0093-691X(92)90096-A10.1016/0093-691X(92)90096-A ↗
73. 10.1016/j.anireprosci.2020.10627910.1016/j.anireprosci.2020.106279 ↗